- Home
- AXL vs CBLL Comparison
AXL vs CBLL Comparison
Compare AXL & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXL
- CBLL
- Stock Information
- Founded
- AXL 1994
- CBLL 2014
- Country
- AXL United States
- CBLL United States
- Employees
- AXL N/A
- CBLL N/A
- Industry
- AXL Auto Parts:O.E.M.
- CBLL
- Sector
- AXL Consumer Discretionary
- CBLL
- Exchange
- AXL Nasdaq
- CBLL Nasdaq
- Market Cap
- AXL 487.5M
- CBLL 538.0M
- IPO Year
- AXL 1999
- CBLL 2024
- Fundamental
- Price
- AXL $4.33
- CBLL $17.18
- Analyst Decision
- AXL Hold
- CBLL Strong Buy
- Analyst Count
- AXL 7
- CBLL 6
- Target Price
- AXL $6.07
- CBLL $33.00
- AVG Volume (30 Days)
- AXL 2.9M
- CBLL 344.7K
- Earning Date
- AXL 05-02-2025
- CBLL 05-08-2025
- Dividend Yield
- AXL N/A
- CBLL N/A
- EPS Growth
- AXL N/A
- CBLL N/A
- EPS
- AXL 0.18
- CBLL N/A
- Revenue
- AXL $5,929,300,000.00
- CBLL $71,535,000.00
- Revenue This Year
- AXL N/A
- CBLL $34.12
- Revenue Next Year
- AXL N/A
- CBLL $28.66
- P/E Ratio
- AXL $24.76
- CBLL N/A
- Revenue Growth
- AXL N/A
- CBLL 44.86
- 52 Week Low
- AXL $3.00
- CBLL $10.01
- 52 Week High
- AXL $7.76
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- AXL 52.11
- CBLL N/A
- Support Level
- AXL $4.21
- CBLL N/A
- Resistance Level
- AXL $4.52
- CBLL N/A
- Average True Range (ATR)
- AXL 0.14
- CBLL 0.00
- MACD
- AXL -0.03
- CBLL 0.00
- Stochastic Oscillator
- AXL 21.30
- CBLL 0.00
About AXL American Axle & Manufacturing Holdings Inc.
American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.